Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gaush Meditech is the largest domestic provider of ophthalmic medical devices in China by revenue. The company offers over 170 products across all major ophthalmology sub-specialties for diagnosis, treatment, and surgery. It has an active R&D pipeline with proprietary innovations in imaging and diagnostic equipment for eye health. Recent clinical results include regulatory approvals for new dry eye diagnostic devices and innovative surgical consumables. The company also operates China's leading online education platform for ophthalmologists with over 50,000 users
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gaush Clear.